Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study.
Álvaro-Gracia JM, Sanchez-Piedra C, Culqui D, Rosello R, Garcia-Dorta A, Campos C, Manrique-Arija S, Ruiz-Montesinos D, Ros-Vilamajo I, Rodríguez-Lozano C, Freire-González M, Caliz R, Bohorquez C, Mateo Soria L, Busquets N, Castrejon I, Sánchez-Alonso F, González-Dávila E, Diaz-Gonzalez F. Álvaro-Gracia JM, et al. Among authors: rosello r. RMD Open. 2023 Mar;9(1):e002936. doi: 10.1136/rmdopen-2022-002936. RMD Open. 2023. PMID: 36927849 Free PMC article.
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
Bethencourt Baute JJ, Sanchez-Piedra C, Ruiz-Montesinos D, Medrano San Ildefonso M, Rodriguez-Lozano C, Perez-Pampin E, Ortiz A, Manrique S, Roselló R, Hernandez V, Campos C, Sellas A, Sifuentes-Giraldo WA, García-González J, Sanchez-Alonso F, Díaz-González F, Gómez-Reino JJ, Bustabad Reyes S; BIOBADASER study group. Bethencourt Baute JJ, et al. Among authors: rosello r. Arthritis Res Ther. 2018 Oct 10;20(1):227. doi: 10.1186/s13075-018-1728-3. Arthritis Res Ther. 2018. PMID: 30305158 Free PMC article.
A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics.
Martín-Martínez MA, Andreu-Sanchez JL, Sanchez-Alonso F, Corominas H, Perez-Venegas JJ, Roman-Ivorra JA, Alperi M, Blanco-Alonso R, Caliz R, Chamizo-Carmona E, Graña-Gil J, Hernández B, Marras C, Mazzucchelli R, Medina Luezas JA, Naranjo-Hernández A, Ortiz A, Roselló R, Sanchez-Nievas G, Sanmartí R, Vela-Casasempere P; en representación del Comité Científico del trabajo Indicador Compuesto para evaluar la calidad asistencial en el manejo de los pacientes con artritis reumatoide en las consultas externas de Reumatología. Martín-Martínez MA, et al. Among authors: rosello r. Reumatol Clin (Engl Ed). 2019 May-Jun;15(3):156-164. doi: 10.1016/j.reuma.2017.06.017. Epub 2017 Aug 6. Reumatol Clin (Engl Ed). 2019. PMID: 28789978 Free article. English, Spanish.
Objectives and methodology of BIOBADASER phase iii.
Sanchez-Piedra C, Hernández Miguel MV, Manero J, Roselló R, Sánchez-Costa JT, Rodríguez-Lozano C, Campos C, Cuende E, Fernández-Lopez JC, Bustabad S, Martín Domenech R, Pérez-Pampín E, Del Pino-Montes J, Millan-Arciniegas AM, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III. Sanchez-Piedra C, et al. Among authors: rosello r. Reumatol Clin (Engl Ed). 2019 Jul-Aug;15(4):229-236. doi: 10.1016/j.reuma.2017.08.001. Epub 2017 Sep 19. Reumatol Clin (Engl Ed). 2019. PMID: 28935290 Free article. English, Spanish.
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F, Blanco R, Calvo-Rio V, Narvaez J, Rubio Romero E, Olivé A, Castañeda S, Gallego Flores A, Hernández MV, Mata C, Ros Vilamajo I, Sifuentes Giraldo WA, Caracuel MA, Freire M, Gómez Arango C, Llobet J, Manrique Arija S, Marras C, Moll-Tuduri C, Plasencia-Rodriguez C, Roselló R, Urruticoechea A, Velloso-Feijoo ML, Del Blanco J, González-Vela MC, Rueda-Gotor J, Pina T, Loricera J, González-Gay MA. Ortiz-Sanjuán F, et al. Among authors: rosello r. Arthritis Rheumatol. 2014 Jun;66(6):1659-65. doi: 10.1002/art.38398. Arthritis Rheumatol. 2014. PMID: 24515813
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V, Acosta Pereira A, Morla R, Ruiz JM, Clavaguera T, Figuls R, Corominas H, Geli C, Roselló R, de Agustín JJ, Alegre C, Pérez C, García A, Rodríguez de la Serna A. Torrente-Segarra V, et al. Among authors: rosello r. Reumatol Clin. 2016 Nov-Dec;12(6):319-322. doi: 10.1016/j.reuma.2015.11.019. Epub 2016 Jan 29. Reumatol Clin. 2016. PMID: 26831256 Free article. English, Spanish.
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study.
Gomez-Reino JJ, Maneiro JR, Ruiz J, Roselló R, Sanmarti R, Romero AB; MIRAR Study Group. Gomez-Reino JJ, et al. Among authors: rosello r. Ann Rheum Dis. 2012 Nov;71(11):1861-4. doi: 10.1136/annrheumdis-2012-201324. Epub 2012 Jun 26. Ann Rheum Dis. 2012. PMID: 22736086 Clinical Trial.
[Tuberculosis infection in an unusual location].
Betrán A, Lavilla MJ, Roselló R, Torres L. Betrán A, et al. Among authors: rosello r. Rev Esp Quimioter. 2020 Jun;33(3):214-215. doi: 10.37201/req/093.2019. Epub 2020 Apr 10. Rev Esp Quimioter. 2020. PMID: 32274907 Free PMC article. Spanish. No abstract available.
75 results